CONMED CORPORATION Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax
CONMED CORPORATION (CNMD) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax of $3.89 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax · last filed 2026-07-29
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax for the quarter ending 2026-06-30 was $3.89M.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax for the quarter ending 2025-12-31 was $2.12M, a 84.00% decline year-over-year.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax for the quarter ending 2025-09-30 was $4.39M.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax for the quarter ending 2025-06-30 was -$9.93M.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax for fiscal 2025 was -$7.10M, a 164.97% decline from fiscal 2024.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax for fiscal 2024 was $10.93M, a 99.09% increase from fiscal 2023.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax for fiscal 2023 was $5.49M, a 62.13% decline from fiscal 2022.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax for fiscal 2022 was $14.49M, a 67.56% increase from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax 9 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.89M 10-Q · filed 2026-07-29 | $7.85M 10-Q · filed 2026-07-29 | ||
| 2025-12-31 | $2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $6.51M derived: sum of 2 quarters · filed 2026-02-17 | -$3.42M derived: sum of 3 quarters · filed 2026-07-29 | -$7.10M 10-K · filed 2026-02-17 |
| 2025-09-30 | $4.39M 10-Q · filed 2025-11-06 | -$5.54M derived: sum of 2 quarters · filed 2026-07-29 | -$9.22M 10-Q · filed 2025-11-06 | $4.03M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | -$9.93M 10-Q · filed 2026-07-29 | -$13.60M 10-Q · filed 2026-07-29 | -$362.00K derived: sum of 3 quarters · filed 2026-07-29 | -$9.44M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | -$3.68M 10-Q · filed 2025-05-01 | $9.56M derived: sum of 2 quarters · filed 2026-02-17 | $492.00K derived: sum of 3 quarters · filed 2026-02-17 | -$7.00K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-12-31 | $13.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $4.17M derived: sum of 2 quarters · filed 2026-02-17 | $3.67M derived: sum of 3 quarters · filed 2026-02-17 | $10.93M 10-K · filed 2026-02-17 |
| 2024-09-30 | -$9.07M 10-Q · filed 2025-11-06 | -$9.57M derived: sum of 2 quarters · filed 2025-11-06 | -$2.31M 10-Q · filed 2025-11-06 | -$8.30M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | -$499.00K 10-Q · filed 2025-07-31 | $6.76M 10-Q · filed 2025-07-31 | $777.00K derived: sum of 3 quarters · filed 2026-02-17 | $6.96M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $7.26M 10-Q · filed 2025-05-01 | $1.28M derived: sum of 2 quarters · filed 2026-02-17 | $7.46M derived: sum of 3 quarters · filed 2026-02-17 | $10.21M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | -$5.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $198.00K derived: sum of 2 quarters · filed 2026-02-17 | $2.95M derived: sum of 3 quarters · filed 2026-02-17 | $5.49M 10-K · filed 2026-02-17 |
| 2023-09-30 | $6.18M 10-Q · filed 2024-10-31 | $8.93M derived: sum of 2 quarters · filed 2024-10-31 | $11.47M 10-Q · filed 2024-10-31 | $1.27M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $2.75M 10-Q · filed 2024-08-01 | $5.29M 10-Q · filed 2024-08-01 | -$4.91M derived: sum of 3 quarters · filed 2025-02-18 | $6.78M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $2.54M 10-Q · filed 2024-04-25 | -$7.67M derived: sum of 2 quarters · filed 2025-02-18 | $4.03M derived: sum of 3 quarters · filed 2025-02-18 | $13.79M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | -$10.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $1.49M derived: sum of 2 quarters · filed 2025-02-18 | $11.25M derived: sum of 3 quarters · filed 2025-02-18 | $14.49M 10-K · filed 2025-02-18 |
| 2022-09-30 | $11.70M 10-Q · filed 2023-10-26 | $21.45M derived: sum of 2 quarters · filed 2023-10-26 | $24.70M 10-Q · filed 2023-10-26 | $26.57M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $9.76M 10-Q · filed 2023-07-27 | $13.00M 10-Q · filed 2023-07-27 | $14.88M derived: sum of 3 quarters · filed 2024-02-28 | $18.06M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $3.25M 10-Q · filed 2023-04-27 | $5.12M derived: sum of 2 quarters · filed 2024-02-28 | $8.31M derived: sum of 3 quarters · filed 2024-02-28 | $8.30M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $5.06M derived: sum of 2 quarters · filed 2024-02-28 | $5.06M derived: sum of 3 quarters · filed 2024-02-28 | $8.65M 10-K · filed 2024-02-28 |
| 2021-09-30 | $3.19M 10-Q · filed 2022-10-27 | $3.19M derived: sum of 2 quarters · filed 2022-10-27 | $6.78M 10-Q · filed 2022-10-27 | $2.19M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | -$3.00K 10-Q · filed 2022-07-28 | $3.59M 10-Q · filed 2022-07-28 | -$995.00K derived: sum of 3 quarters · filed 2023-02-21 | -$4.54M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $3.59M 10-Q · filed 2022-05-05 | -$992.00K derived: sum of 2 quarters · filed 2023-02-21 | -$4.53M derived: sum of 3 quarters · filed 2023-02-21 | -$7.81M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | -$4.58M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | -$8.13M derived: sum of 2 quarters · filed 2023-02-21 | -$11.41M derived: sum of 3 quarters · filed 2023-02-21 | -$7.11M 10-K · filed 2023-02-21 |
| 2020-09-30 | -$3.54M 10-Q · filed 2021-10-28 | -$6.82M derived: sum of 2 quarters · filed 2021-10-28 | -$2.53M 10-Q · filed 2021-10-28 | -$5.41M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | -$3.28M 10-Q · filed 2021-07-29 | $1.01M 10-Q · filed 2021-07-29 | -$1.86M derived: sum of 3 quarters · filed 2022-02-22 | $3.02M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $4.29M 10-Q · filed 2021-04-29 | $1.42M derived: sum of 2 quarters · filed 2022-02-22 | $6.30M derived: sum of 3 quarters · filed 2022-02-22 | $6.43M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | -$2.88M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $2.01M derived: sum of 2 quarters · filed 2022-02-22 | $2.13M derived: sum of 3 quarters · filed 2022-02-22 | $3.87M 10-K · filed 2022-02-22 |
| 2019-09-30 | $4.89M 10-Q · filed 2020-10-29 | $5.01M derived: sum of 2 quarters · filed 2020-10-29 | $6.75M 10-Q · filed 2020-10-29 | $9.62M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | $126.00K 10-Q · filed 2020-07-30 | $1.86M 10-Q · filed 2020-07-30 | $4.74M derived: sum of 3 quarters · filed 2021-02-22 | $6.45M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-03-31 | $1.74M 10-Q · filed 2020-04-30 | $4.61M derived: sum of 2 quarters · filed 2021-02-22 | $6.32M derived: sum of 3 quarters · filed 2021-02-22 | $10.98M derived: sum of 4 quarters · filed 2021-02-22 |
| 2018-12-31 | $2.87M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $4.58M derived: sum of 2 quarters · filed 2021-02-22 | $9.24M derived: sum of 3 quarters · filed 2021-02-22 | $10.07M 10-K · filed 2021-02-22 |
| 2018-09-30 | $1.71M 10-Q · filed 2019-10-31 | $6.37M derived: sum of 2 quarters · filed 2019-10-31 | $7.20M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $4.66M 10-Q · filed 2019-08-01 | $5.49M 10-Q · filed 2019-08-01 | ||
| 2017-12-31 | -$7.29M 10-K · filed 2020-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |